Cargando…
Structure based innovative approach to analyze aptaprobe–GPC3 complexes in hepatocellular carcinoma
BACKGROUND: Glypican-3 (GPC3), a membrane-bound heparan sulfate proteoglycan, is a biomarker of hepatocellular carcinoma (HCC) progression. Aptamers specifically binding to target biomolecules have recently emerged as clinical disease diagnosis targets. Here, we describe 3D structure-based aptaprobe...
Autores principales: | Shin, Woo-Ri, Park, Dae-Young, Kim, Ji Hun, Lee, Jin-Pyo, Thai, Nguyen Quang, Oh, In-Hwan, Sekhon, Simranjeet Singh, Choi, Wooil, Kim, Sung Yeon, Cho, Byung-Kwan, Kim, Sun Chang, Min, Jiho, Ahn, Ji-Young, Kim, Yang-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044640/ https://www.ncbi.nlm.nih.gov/pubmed/35477501 http://dx.doi.org/10.1186/s12951-022-01391-z |
Ejemplares similares
-
Cyclophilin A‐mediated mitigation of coronavirus SARS‐CoV‐2
por: Sekhon, Simranjeet Singh, et al.
Publicado: (2022) -
Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency
por: Kim, Sun Chang, et al.
Publicado: (2021) -
Detecting and Discriminating Shigella sonnei Using an Aptamer-Based Fluorescent Biosensor Platform
por: Song, Myeong-Sub, et al.
Publicado: (2017) -
Aptamer-based Sandwich Assay and its Clinical Outlooks for Detecting Lipocalin-2 in Hepatocellular Carcinoma (HCC)
por: Lee, Kyeong-Ah, et al.
Publicado: (2015) -
Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer
por: Park, Jun Young, et al.
Publicado: (2020)